Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
Durable response rate to anti-PD-1/PD-L1 therapy remains relatively low in patients with cancer. Here the authors show that metformin-loaded mannose-modified macrophage-derived microparticles reprogram the tumor immune microenvironment and improve responses to anti-PD-1 therapy.
Guardado en:
Autores principales: | Zhaohan Wei, Xiaoqiong Zhang, Tuying Yong, Nana Bie, Guiting Zhan, Xin Li, Qingle Liang, Jianye Li, Jingjing Yu, Gang Huang, Yuchen Yan, Zelong Zhang, Bixiang Zhang, Lu Gan, Bo Huang, Xiangliang Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c971cb339bd0453ca49a321d5bcad548 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
por: Tuying Yong, et al.
Publicado: (2019) -
Organic multicomponent microparticle libraries
por: Dandan Zhang, et al.
Publicado: (2021) -
Vaporization, Diffusion and Combustion of Laser-Induced Individual Magnesium Microparticles in Inert and Oxidizing Atmospheres
por: Fan Yang, et al.
Publicado: (2021) -
Microparticles and PD1 interplay added a prognostic impact in treatment outcomes of patients with multiple myeloma
por: Asmaa M. Zahran, et al.
Publicado: (2021) -
Electronic and lattice strain dual tailoring for boosting Pd electrocatalysis in oxygen reduction reaction
por: Qing Zeng, et al.
Publicado: (2021)